Drawing for ONWARD TOGETHER

USPTO serial 87166541

ONWARD TOGETHER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BULLOFF, TOBY ELLEN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONWARD TOGETHER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; downloadable mobile application for medical and condition support for the treatment of diabetes; downloadable mobile application for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; downloadable mobile application intended for diabetic patients for recording blood test results from a blood glucose monitor; software downloadable via the internet or downloadable mobile applications for monitoring and tracking blood glucose levelsACTIVE—
010Medical monitors for the detection, measurement and monitoring of physiological substances relating to diabetes, and parts and components thereof; blood glucose monitors; blood glucose monitors sold as a unit with blood glucose monitoring kits comprising strips for measuring blood glucose concentrations, lancets and control solution; medical equipment for monitoring diabetes, namely, sensors for measuring blood glucose levels, sensors for biotechnology applications, apparatus for measuring dosages and delivering pharmaceuticals, and apparatus for drawing or sampling blood or other bodily fluids; injectable insulin pens sold empty; insulin pumps for medical use sold empty; blood monitoring apparatusACTIVE—
038Transmission of digital files; transmission of information and images via wireless communication networks regarding healthcare; transmission of information for others in the field of healthcare; transmission of information addressed to patients or healthcare professionals via wireless communication networks; transmission of information and images relating to pharmaceuticals and medicine via all means of telecommunication including the Internet and wireless communication networks; transmission of information via electronic communication networks and wireless communication networks; transmission of information in the field of diabetes; radio broadcasting service; provision of online forums and electronic bulletin boards for the transmission of messages among computer users in the pharmaceutical, medical, and healthcare fields; provision of internet chat roomsACTIVE—
042Software as a services (SAAS) featuring software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients for purposes of monitoring blood glucose levels and for purposes of facilitating the exchange of medical data and medical advice for the treatment of diabetes; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditionsACTIVE—
044Provision of medical and condition support for the treatment of diabetes, by way of a mobile application; provision of medical information for doctors, patients, and caregivers in the field of diabetes; provision of medical and pharmaceutical health care information and advice in the field of diabetes; health care consulting in the field of diabetes; disease management programs in the field of diabetes; provision of medical information and educational information in the field of healthcare; health care services; medical consultation; disease management programs concerning healthcare; provision of medical information via the Internet; provision of health and pharmaceutical health care informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 13, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 13, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Feb 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 9, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 16, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 16, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 16, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 16, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 16, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 15, 2016DOCKASSIGNED TO EXAMINER—
Sep 30, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 22, 2016ALIEASSIGNED TO LIE—
Sep 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 13, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 13, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance